DIA 2013 49th Annual Meeting
Click here to go to the previous page
Pharmaceutical Project Management: What's Really Important and How Can We Do Better?
Track
:
Track 02: Project/Portfolio Management and Strategic Planning
Program Code:
366
Date:
Wednesday, June 26, 2013
Time:
4:00 PM to 5:30 PM
EST
Location:
104C
CHAIR
:
SPEAKER
(S):
Robin G Foldesy, PhD (SPKNON), Vice President, Strategic Drug Development, Quintiles Transnational Corp., United States Mary Lou Bell, Head, Portfolio and Program Management, Head, Portfolio and Program Management, Nimbus Discovery, United States
Description
Project management (PM) plays an important role in pharma and biotech companies, but what can we do to further improve, particularly in today's environment? Come and hear the critical findings from a panel of PM practitioners and experts.
This session has been developed by the Project Management Community.
This session has been developed by the Project Management Community.
This session is a part of:
This session is a part of: